Yugrafarm Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 120

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Yugrafarm General Information

Description

Producer of pharmaceutical products. The company produces and delivers drugs such as ReoDEKS, ReoHES and glucose 5% (500ml) over the counter.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Acquirer
Pharmasyntez
Corporate Office
  • 7 km Velizhansky tract, d. 2
  • Tyumen, 625059
  • Russia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yugrafarm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Yugrafarm‘s full profile, request access.

Request a free trial

Yugrafarm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yugrafarm Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Yugrafarm‘s full profile, request access.

Request a free trial

Yugrafarm FAQs

  • When was Yugrafarm founded?

    Yugrafarm was founded in 1997.

  • Where is Yugrafarm headquartered?

    Yugrafarm is headquartered in Tyumen, Russia.

  • What is the size of Yugrafarm?

    Yugrafarm has 120 total employees.

  • What industry is Yugrafarm in?

    Yugrafarm’s primary industry is Drug Delivery.

  • Is Yugrafarm a private or public company?

    Yugrafarm is a Private company.

  • What is Yugrafarm’s current revenue?

    The current revenue for Yugrafarm is 00000.

  • Who are Yugrafarm’s investors?

    AO Ugoria Insurance has invested in Yugrafarm.

  • When was Yugrafarm acquired?

    Yugrafarm was acquired on 26-Jan-2015.

  • Who acquired Yugrafarm?

    Yugrafarm was acquired by Pharmasyntez.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »